Received Apr 30, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | 947357 | IM / LA |
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | 1 | Y017625 | IM / LA |
Dose given when labs showed immunity to Hep A. Patient denied adverse effects.
Hep A showed Immunity